Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.2450
-0.0050 (-2.00%)
At close: Feb 19, 2026
Imugene Market Cap
Imugene has a market cap or net worth of 80.38 million as of February 18, 2026. Its market cap has decreased by -70.06% in one year.
Market Cap
80.38M
Enterprise Value
69.10M
Revenue
4.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
Market Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 80.38M, an increase of 989.33%. That is a compound annual growth rate of 10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 80.38M | -30.56% |
| Dec 31, 2025 | 115.75M | -57.94% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 109.06M |
| Arovella Therapeutics | 102.44M |
| LTR Pharma | 94.52M |
| Cynata Therapeutics | 90.66M |
| Alterity Therapeutics | 87.00M |
| Radiopharm Theranostics | 77.97M |
| EZZ Life Science Holdings | 76.92M |
| Neurizon Therapeutics | 67.49M |